Evidence method
Level · gp.fundamentals.debt_to_revenue
498.39% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
GH · Mar 31, 2026
Guardant Health, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001576280-26-000026General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.85% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-21.75% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
48.26% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
27.80% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
65.22% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-40.23% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
30.18% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
15.78% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History22 statesSelf-history eligible
Sep 30, 20210/7 normalizedLevel 3Dec 31, 20210/7 normalizedLevel 3Mar 31, 20226/7 normalizedLevel 3Jun 30, 20226/7 normalizedLevel 3Sep 30, 20226/7 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20237/7 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20237/7 normalizedLevel 3Mar 31, 20247/7 normalizedLevel 3Jun 30, 20247/7 normalizedLevel 3Sep 30, 20247/7 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/9 normalizedLevel 3Jun 30, 20257/9 normalizedLevel 3Sep 30, 20257/9 normalizedLevel 3Dec 31, 20257/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 153.15%
- Current
- 498.39%
- Delta
- 345.24%
- Previous
- 4.92%
- Current
- 1.85%
- Delta
- -3.07%
- Previous
- -18.81%
- Current
- -21.75%
- Delta
- -2.94%
- Previous
- 32.88%
- Current
- 48.26%
- Delta
- 15.38%
- Previous
- 8.74%
- Current
- 27.80%
- Delta
- 19.05%
- Previous
- 64.46%
- Current
- 65.22%
- Delta
- 0.76%
- Previous
- -44.53%
- Current
- -40.23%
- Delta
- 4.30%
- Previous
- 37.09%
- Current
- 30.18%
- Delta
- -6.91%
- Previous
- 16.93%
- Current
- 15.78%
- Delta
- -1.14%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Analogous To · GH state analogue 2 →Has State · Guardant Health, Inc. →Transitioned To · GH Fundamental State →Transitioned To · GH BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · GH CAPEX_INTENSITY_DECREASED →Transitioned To · GH CASH_GENERATION_DECREASED →Transitioned To · GH GROWTH_INCREASED →Transitioned To · GH INVENTORY_PRESSURE_INCREASED →Transitioned To · GH MARGIN_INCREASED →Transitioned To · GH PROFITABILITY_INCREASED →Transitioned To · GH R_AND_D_INTENSITY_DECREASED →Transitioned To · GH SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.